Identification of genetic markers to 20 NIDDM candidate genes by radiation hybrid analysis Dear Sir, We have determined the fine chromosomal localization of 20 candidate genes for non-insulin-dependent diabetes (NID-DM) using radiation hybrid analysis [1] in an effort to identify short tandem repeat markers suitable for the genetic analysis of these genes in disease populations. Loci for which markers were identified include: leptin and its receptor, AMP kinase activated protein kinase, hexokinase II, pyruvate carboxylase, glutamine : fructose 6-phosphate amidotransferase (GFAT), islet regenerating protein, glucose 6-phosphatase, adrenoreceptors a2 a, a2 b, and a2 c, beta3 adrenoceptor, liver mitochondrial carnitine palmitoyltransferase I, ras associated with diabetes (RAD), pancreatic polypeptide Y, neuropeptide Y receptor 5, phenylethanolamine-N-methyltransferase, ATP citrate lyase, pyruvate dehydrogenase kinase 4, and the agouti switch protein. Candidates were chosen because biochemical or physiological evidence suggests they play a role in aspects of metabolism which may be involved in the aetiology of NID-DM.
Primers to candidate genes were developed or otherwise obtained based upon published nucleotide sequences. Primers to GFAT were derived from partial genomic sequence obtained from a P1 clone DMPC-HFFF1-802E1 (Genome Systems Inc., St. Louis, Mo. USA) identified by hybridization to GFAT cDNA consisting of bp 123±2168 of genbank accession number M90516. Primers to leptin were designed to amplify a CTTT tetranucleotide repeat contained within bp 4211±4477 of the gene (genbank accession number D63710). Primer sequences were LEPT1 5¢-FAM-TCAACAAACCATTCT-GAGTTC-3¢ and LEPT2 5¢-TGGGACACATGTTCTCAG-GA-3¢. The repeat was found to be highly informative in the 43 unrelated CEPH individuals genotyped (heterozygosity = 0.83) and should thus serve as a good marker to genetically evaluate the contribution of leptin to human disease.
Primer pairs to these genes were then optimized for mapping onto the Stanford G3 and Genebridge GB4 radiation hybrid panels (Research Genetics, Huntsville, Ala., USA). Marker retention data was analysed using RHMAP Version 2.01 for the G3 data or the Whitehead Institute-MIT Center for Genome Research radiation hybrid mapping web sever for the GB4 data. Distance relationships to nearby polymorphic markers were established using the statistical package RHMAPPER and RH2PT [2, 3] .
Candidate gene markers in Table 1 are those with reported heterozygosities greater than 60 % and estimated to be not more than two megabases (Mb) (66.7 centirays [Cr]) from the candidate gene based on two-point analysis of Stanford G3 panel retention data. In about half of the cases, markers were determined to be within 1 Mb (33.3 cR) of the gene. For some loci, approximate distances from markers had to be inferred by comparing both G3 and GB4 data because of gaps in the map data available from the European Bioinformatics Institute (EBI) [4] . In addition, a marker was nominated for a candidate gene only after one or more of the following conditions was met: 1) proximity to the marker was confirmed by an independent sequence tag site (STS) within the gene; 2) proximity to the marker was confirmed by an independent radiation hybridization (RH) panel; or 3) the candidate gene and nominated marker were part of a linkage group supported with a two-locus logarithm of odds (LOD) score of at least three using RH2PT.
Incorporation of NIDDM candidate gene markers, such as those reported here, within a genome scan will ensure that genes which play a role in insulin action, obesity, energy and glucose metabolism are evaluated for their role in genetic susceptibility to the disease. RH analysis offers a rapid and precise way to localize genes with respect to anonymous markers or other genes and thus offers an advantage over methods such as meiotic mapping or fluorescent in situ hybridization (FISH). Even when polymorphic markers are known to exist within the candidate gene, such as with RAD and hexokinase II, it is often desirable to identify other nearby markers that can be more conveniently included within a genome scan set or that are more informative in a particular study population. RH analysis offers a rapid method of identifying these markers.
Analysis of 20 NIDDM candidate genes by RH analysis has led to the identification of a polymorphic marker within 2cM (~2Mb) of each gene. A highly informative marker to leptin has also been identified. These markers will prove to be important tools in the ongoing search for diabetes susceptibility loci. 
